Cargando…

Further Observations on Protamine Zinc Insulin in Clinical Diabetes

Detalles Bibliográficos
Autor principal:	Bose, J. P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Thacker 1939
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5151626/ https://www.ncbi.nlm.nih.gov/pubmed/29011905

Ejemplares similares

Protamine Zinc Insulin
por: Bose, J. P.
Publicado: (1938)

Protamine Zinc Insulin
Publicado: (1937)

Zinc Protamine Insulin
por: Dunlop, D. M.
Publicado: (1938)

Protamine zinc insulin combined with sodium selenite improves glycometabolism in the diabetic KKAy mice
por: Lu, Juan, et al.
Publicado: (2016)

The Use of Protamine Insulin
por: Nixon, J. A.
Publicado: (1938)

Prevention of Postprandial Hyperglycemia by Ophthalmic Nanoparticles Based on Protamine Zinc Insulin in the Rabbit
por: Deguchi, Saori, et al.
Publicado: (2021)

Use of Insulin Lispro Protamine Suspension in Pregnancy
por: Lapolla, Annunziata, et al.
Publicado: (2015)

Clinical experience of switching from glargine or neutral protamine Hagedorn insulin to insulin detemir in type 2 diabetes: Observations from the Indian cohort in the A(1)chieve study
por: Wangnoo, Subhash Kumar, et al.
Publicado: (2014)

Protamine-containing insulin allergy and renal dysfunction in a patient with type 2 diabetes
por: Wu, Wenjun, et al.
Publicado: (2015)

Modulation of insulin dose titration using a hypoglycaemia-sensitive algorithm: insulin glargine versus neutral protamine Hagedorn insulin in insulin-naïve people with type 2 diabetes
por: Home, P D, et al.
Publicado: (2015)

Formation of Protamine and Zn–Insulin Assembly: Exploring Biophysical Consequences
por: Aggarwal, Soumya, et al.
Publicado: (2022)

Further Observations on the Effect of Opium on Blood Sugar
por: Chopra, R. N., et al.
Publicado: (1931)

A randomized trial comparing perinatal outcomes using insulin detemir or neutral protamine Hagedorn in type 1 diabetes
por: Hod, Moshe, et al.
Publicado: (2014)

Cost Effectiveness of Insulin Glargine versus Neutral Protamin Hagedorn Insulin in the Treatment of Type 2 Diabetes Patients in Turkey
por: Satman, Ilhan, et al.
Publicado: (2013)

Clinical trial of protamine in the treatment of malignant diseases.
por: Wright, J. E.
Publicado: (1968)

Administration of Protamine Through Radial Arterial Access: A Prospective Observational Study
por: Goyal, Priyanka, et al.
Publicado: (2021)

Glycemic Control in Hospitalized Patients with Diabetes Receiving Corticosteroids Using a Neutral Protamine Hagedorn Insulin Protocol: A Randomized Clinical Trial
por: Khowaja, Ameer, et al.
Publicado: (2018)

Long‐term field study of lispro and neutral protamine Hagedorn insulins treatment in dogs with diabetes mellitus
por: Kuzi, Sharon, et al.
Publicado: (2023)

390 Protamine Allergy
por: Hafner, Christine, et al.
Publicado: (2012)

Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study
por: Rosenstock, J., et al.
Publicado: (2009)

Comparison of Insulin Lispro Protamine Suspension with NPH Insulin in Pregnant Women with Type 2 and Gestational Diabetes Mellitus: Maternal and Perinatal Outcomes
por: Colatrella, Antonietta, et al.
Publicado: (2013)

A randomised, open-labelstudy of insulin glargine or neutral protamine Hagedorn insulin in Chinese paediatric patients with type 1 diabetes mellitus
por: Liu, Min, et al.
Publicado: (2016)

Protamine-Induced Bradycardic Arrest in a Diabetic Patient
por: McDonald, Brooke A, et al.
Publicado: (2020)

Nursing Observation of Improved Administration Route of Protamine Sulfate Neutralizing Heparin
por: Hu, Jia, et al.
Publicado: (2022)

Studies on the Hemolytic Properties of Protamine
por: Becker, Frederick F.
Publicado: (1961)

Successful desensitization with human insulin in a patient with an insulin allergy and hypersensitivity to protamine: a case report
por: Pföhler, Claudia, et al.
Publicado: (2008)

Protamine as a barrier against the angiogenic effect of insulin: a possible role of apelin
por: Yeganeh-Hajahmadi, Mahboobeh, et al.
Publicado: (2023)

Polymorphisms in Protamine 1 and Protamine 2 predict the risk of male infertility: a meta-analysis
por: Jiang, Weijun, et al.
Publicado: (2015)

Loss of the cleaved-protamine 2 domain leads to incomplete histone-to-protamine exchange and infertility in mice
por: Arévalo, Lena, et al.
Publicado: (2022)

PROTAMINE1 and PROTAMINE2 genes expression in the sperms of oligoasthenospermic individuals and intrauterine insemination candidates couples: Is there any significant differences?
por: Aboutorabi, Roshanak, et al.
Publicado: (2016)

Basal Supplementation of Insulin Lispro Protamine Suspension Versus Insulin Glargine and Detemir for Type 2 Diabetes: Meta-analysis of randomized controlled trials
por: Esposito, Katherine, et al.
Publicado: (2012)

Comparing the efficacy and safety of insulin detemir versus neutral protamine hagedorn insulin in treatment of diabetes during pregnancy: a randomized, controlled study
por: ji, Jing, et al.
Publicado: (2020)

Effect of dietary protamine on lipid metabolism in rats
por: Hosomi, Ryota, et al.
Publicado: (2010)

Comparison of insulin lispro protamine suspension versus insulin glargine once daily added to oral antihyperglycaemic medications and exenatide in type 2 diabetes: a prospective randomized open-label trial
por: Arakaki, R F, et al.
Publicado: (2014)

Switching from Neutral Protamine Hagedorn (NPH) Insulin to Insulin Glargine 300 U/mL in Older and Younger Patients with Type 2 Diabetes: A Post Hoc Analysis of a Multicenter, Prospective, Observational Study
por: Wolnik, B., et al.
Publicado: (2022)

Cost-Effectiveness Analysis of Insulin Detemir Compared to Neutral Protamine Hagedorn (NPH) in Patients with Type 1 and Type 2 Diabetes Mellitus in Spain
por: Morales, Cristóbal, et al.
Publicado: (2015)

Indirect comparison of lixisenatide versus neutral protamine Hagedorn insulin as add-on to metformin and sulphonylurea in patients with type 2 diabetes mellitus
por: Fournier, Marie, et al.
Publicado: (2014)

Evaluating the cost-effectiveness of insulin detemir versus neutral protamine Hagedorn insulin in patients with type 1 or type 2 diabetes in the UK using a short-term modeling approach
por: Pollock, Richard F, et al.
Publicado: (2018)

Glycemic Variability and Time in Range During Self-titration of Once Daily Insulin Glargine 300 U/ml Versus Neutral Protamine Hagedorn Insulin in Insulin-naïve Chinese Type 2 Diabetes Patients
por: Ling, James, et al.
Publicado: (2021)

Further Observations on Tetanus
por: Noronha, A. J.
Publicado: (1919)

Cannot write session to /tmp/vufind_sessions/sess_a36bo3kt36m5hv8fgfqqu1hk8r